BFM Podcast

Access to Medicine – Patents versus Patients

Tan KW
Publish date: Mon, 07 Jan 2019, 06:00 PM

Fifa Rahman, Board Member, Unitaid NGO Delegation | Mark Cheong, Pharmacist, Monash University

07-Jan-19 17:00

 

Price gouging in the pharmaceutical industry has become a common feature of health news. Who can forget Martin Shkreli’s infamous price hike of the HIV drug Daraprim, which went from USD13.50 to $750 in the summer of 2015? Are international laws tough enough to ensure that the bottom line is the people and not profit?

 

 

Produced by: Tina Carmillia

Presented by: Meera Sivasothy

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment